The Basque nanomedicine field is to be congratulated. The European Commission has made a positive assessment of two important projects from two European consortia led by Basque entities to start up pilot plants for the manufacture of nanodrugs under sterile conditions. These projects, which are in the final phase of negotiation and implementation, are led by the IK4-CIDETEC technology centre and the Midatech Biogune company respectively, and the sum of both has a financial award of 14.28 million euros.
Enara Herran, a researcher at the UPV/EHU’s Department of Pharmacy and Pharmaceutical Technology, is working to improve the way Alzheimer’s and Parkinson’s treatments are administered. And it is a fact that, as Herran herself stressed, "both diseases are becoming more and more common in our society”.
Lesions in the peripheral nervous system, usually arising from traumatic accidents, are caused by the interruption of a nerve signal because the nerve has been severed. This kind of lesion, giving rise to more than 1,000,000 medical appointments every year in the West, can result in loss of motor control and of sensorial perception. Given the gravity of this pathology and its widespread incidence, microtechnologies are leading to the generation of new ways to reverse it.
The Annual Event & General Assembly of the European Technology Platform on Nanomedicine (ETPM) will take place on 15 and 16 October in San Sebastian. The event will be held at the CIC nanoGUNE nanoscience Cooperative Research Centre facilities, and is co-organised by this organisation and the Basque Government's nanoBasque agency.
Place: CIC nanoGUNE. Donostia
Place: DIPC. Donostia